Evidence map›Paper›PMID 28165397›Full record

ReviewVaccines2017

Human T Cell Memory: A Dynamic View.

Derek C Macallan, José A M Borghans, Becca Asquith

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Article
  3. Antigen-specific TScience advances · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  9. Review
  10. Review
  11. Epitope mapping ofHeliyon · 2023
    Article
  12. Article
  13. Article
  14. Modeling T Cell Fate.Annual review of immunology · 2023
    Review
  15. Article
  16. Heterogeneity of memory T cells in aging.Frontiers in immunology · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Derek C MacallanInstitute for Infection & Immunity, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK. macallan@sgul.ac.uk.
José A M BorghansLaboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands. j.borghans@umcutrecht.nl.
Becca AsquithDepartment of Medicine, Imperial College London W2 1PG, UK. r.asquith@ic.ac.uk.
Imperial College London · GBSt George's, University of London · GBUniversity Medical Center Utrecht · NL

Funding

Medical Research Council G0601072Medical Research Council G1001052Medical Research Council MR/J007439/1
6 · The paper itself

Abstract

Long-term T cell-mediated protection depends upon the formation of a pool of memory cells to protect against future pathogen challenge. In this review we argue that looking at T cell memory from a dynamic viewpoint can help in understanding how memory populations are maintained following pathogen exposure or vaccination. For example, a dynamic view resolves the apparent paradox between the relatively short lifespans of individual memory cells and very long-lived immunological memory by focussing on the persistence of clonal populations, rather than individual cells. Clonal survival is achieved by balancing proliferation, death and differentiation rates within and between identifiable phenotypic pools; such pools correspond broadly to sequential stages in the linear differentiation pathway. Each pool has its own characteristic kinetics, but only when considered as a population; single cells exhibit considerable heterogeneity. In humans, we tend to concentrate on circulating cells, but memory T cells in non-lymphoid tissues and bone marrow are increasingly recognised as critical for immune defence; their kinetics, however, remain largely unexplored. Considering vaccination from this viewpoint shifts the focus from the size of the primary response to the survival of the clone and enables identification of critical system pinch-points and opportunities to improve vaccine efficacy.

Indexed as

dynamicsimmune memorykineticsproliferationsurvivalturnovervaccinationvaccine

Identifiers

PMID28165397
PMCPMC5371741
OpenAlexW2586387227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.